Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review.

Capizzano AA, Jorge RE, Acion LC, Robinson RG.

J Magn Reson Imaging. 2007 Dec;26(6):1378-89. Review.

PMID:
17968885
2.

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.

Cecil KM, DelBello MP, Sellars MC, Strakowski SM.

J Child Adolesc Psychopharmacol. 2003 Winter;13(4):545-55.

PMID:
14977467
3.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
4.

Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology.

Sanches RF, Crippa JA, Hallak JE, Araújo D, Zuardi AW.

Rev Hosp Clin Fac Med Sao Paulo. 2004 Jun;59(3):145-52. Epub 2004 Jul 28. Review.

5.

Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.

de Araújo Filho GM, Lin K, Lin J, Peruchi MM, Caboclo LO, Guaranha MS, Guilhoto LM, Carrete H Jr, Yacubian EM.

Epilepsia. 2009 May;50(5):1201-9. doi: 10.1111/j.1528-1167.2009.02021.x. Epub 2009 Mar 11.

6.

Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.

Guan JT, Xu XH, Geng YQ, Yu XJ, Wu RH.

Brain Res. 2008 Aug 28;1227:221-5. doi: 10.1016/j.brainres.2008.06.019. Epub 2008 Jun 19.

PMID:
18602897
7.

Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.

Scherk H, Backens M, Schneider-Axmann T, Kemmer C, Usher J, Reith W, Falkai P, Gruber O.

Acta Psychiatr Scand. 2008 Apr;117(4):283-8. doi: 10.1111/j.1600-0447.2007.01142.x. Epub 2008 Jan 16.

PMID:
18205896
8.

Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.

Franczak M, Prost RW, Antuono PG, Mark LP, Jones JL, Ulmer JL.

J Comput Assist Tomogr. 2007 Sep-Oct;31(5):666-70.

PMID:
17895774
9.

Correlation study of optimized voxel-based morphometry and (1)H MRS in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

Brázdil M, Marecek R, Fojtíková D, Mikl M, Kuba R, Krupa P, Rektor I.

Hum Brain Mapp. 2009 Apr;30(4):1226-35. doi: 10.1002/hbm.20589.

PMID:
18609565
10.

Proton magnetic resonance spectroscopy in school-aged autistic children.

Vasconcelos MM, Brito AR, Domingues RC, da Cruz LC Jr, Gasparetto EL, Werner J Jr, Gonçalves JP.

J Neuroimaging. 2008 Jul;18(3):288-95. doi: 10.1111/j.1552-6569.2007.00200.x.

PMID:
18304036
11.

Proton magnetic resonance spectroscopy of late-life major depressive disorder.

Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.

Psychiatry Res. 2009 Jun 30;172(3):210-4. doi: 10.1016/j.pscychresns.2009.01.003. Epub 2009 Mar 20.

PMID:
19303260
12.

Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study.

Senaratne R, Milne AM, MacQueen GM, Hall GB.

Psychiatry Res. 2009 Jun 30;172(3):205-9. doi: 10.1016/j.pscychresns.2008.07.007. Epub 2009 Apr 21.

PMID:
19386476
13.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
14.

Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy.

Modi S, Bhattacharya M, Sekhri T, Rana P, Tripathi RP, Khushu S.

Magn Reson Imaging. 2008 Apr;26(3):420-5. doi: 10.1016/j.mri.2007.08.011.

PMID:
18164573
15.

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

Rowland L, Bustillo JR, Lauriello J.

Semin Clin Neuropsychiatry. 2001 Apr;6(2):121-30. Review.

PMID:
11296312
16.

Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.

Lin K, Carrete H Jr, Lin J, Peruchi MM, de Araújo Filho GM, Guaranha MS, Guilhoto LM, Sakamoto AC, Yacubian EM.

Epilepsia. 2009 May;50(5):1191-200. doi: 10.1111/j.1528-1167.2008.01948.x. Epub 2009 Feb 12.

17.

Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.

Hermens DF, Naismith SL, Chitty KM, Lee RS, Tickell A, Duffy SL, Paquola C, White D, Hickie IB, Lagopoulos J.

Eur Neuropsychopharmacol. 2015 Jun;25(6):836-45. doi: 10.1016/j.euroneuro.2015.02.009. Epub 2015 Mar 5.

PMID:
25795519
18.

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.

Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.

Psychiatry Clin Neurosci. 2009 Jun;63(3):350-6. doi: 10.1111/j.1440-1819.2009.01951.x.

19.

Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.

Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E.

Psychiatry Clin Neurosci. 2009 Aug;63(4):486-90. doi: 10.1111/j.1440-1819.2009.01993.x. Epub 2009 Jun 15.

20.

Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.

Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I.

Epilepsia. 2009 Mar;50(3):486-92. doi: 10.1111/j.1528-1167.2008.01801.x. Epub 2008 Oct 3.

Supplemental Content

Support Center